# OnCo record acosog-z1071 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/acosog-z1071/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "acosog-z1071", "NCT00881361" ;
  schema:name "ACOSOG Z1071 (Alliance)"@en ;
  schema:alternateName "Z1071"@en ;
  schema:description "When chemotherapy is given first and clears the lymph nodes, can a surgeon trust the sentinel node to prove it? Z1071 found the sentinel node missed residual cancer about one time in eight, which is too often, and that finding forced the technique to be redesigned."@en ;
  schema:url <https://onco.cc/trials/acosog-z1071/> ;
  schema:dateModified "2026-09-25"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT00881361>, <https://doi.org/10.1001/jama.2013.278932> ;
  onco:status "negative" ;
  onco:phase "2" ;
  onco:cancers <https://onco.cc/cancers/breast-cancer/>, <https://onco.cc/cancers/breast-hr-positive/>, <https://onco.cc/cancers/breast-her2-positive/>, <https://onco.cc/cancers/tnbc/> ;
  onco:technologies <https://onco.cc/technologies/sentinel-node/> ;
  onco:companies <https://onco.cc/companies/alliance-oncology/> ;
  onco:terms <https://onco.cc/terms/sentinel-lymph-node-biopsy/>, <https://onco.cc/terms/targeted-axillary-dissection/>, <https://onco.cc/terms/neoadjuvant-versus-adjuvant-breast/>, <https://onco.cc/terms/pcr/> ;
  onco:trials <https://onco.cc/trials/targeted-axillary-dissection-md-anderson/>, <https://onco.cc/trials/atnec/> .